Experience

Stibbe advises a leading pharmaceutical company

Stibbe advises a leading pharmaceutical company

Stibbe advises a leading pharmaceutical company

10.04.2013 BE law

Assisting our client in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredient and for combination products that are registered based on a well-established use.

The strategy we developed for the client consists of mixing the various types of product registration to influence pricing/reimbursement. It is essential for our client to differentiate its products from those of its competitors so that it could mitigate the impact of price cuts imposed by the authorities.

Team

Related experience

This website uses cookies. Some of these cookies are essential for the technical functioning of our website and you cannot disable these cookies if you want to read our website. We also use functional cookies to ensure the website functions properly and analytical cookies to personalise content and to analyse our traffic. You can either accept or refuse these functional and analytical cookies.

Privacy – en cookieverklaring